Does correction of metabolic acidosis improve thyroid and growth hormone axes in haemodialysis patients?
CMA contributes to the derangements of the growth and thyroid hormone axes and to hypoalbuminaemia, but is not a modulator of systemic inflammation in dialysis patients. Correcting CMA may improve nutritional and metabolic parameters and thus lower morbidity and mortality.
Age and tactile perceptual abilities have additive effects on the acceptance of creams with different textures when applied to the forearm.